Gilead Sciences signs voluntary licensing agreement with six pharma firms to produce generic lenacapavir: Our Bureau, New Delhi Thursday, October 3, 2024, 11:30 Hrs [IST] US-based ...

The drug is currently approved for treating heavily treatment-experienced (HTE) adults with multi-drug resistant HIV.

Stay up-to-date with the Dr. Reddy's Laboratories Stock Liveblog, your trusted source for real-time updates and thorough ...

Ambassador Parvathaneni Harish, India’s permanent representative to the United Nations, offered tributes to Mahatma Gandhi on ...

Dr Reddy’s Laboratories said it has entered into a royalty-free non-exclusive voluntary licensing agreement with Gilead ...

While Urinary Tract Infection UTI mostly causes urinary problems many wonder whether it can also lead to non-specific ...

Dr Reddy's Laboratories and Hetero sign non-exclusive, royalty-free agreements with Gilead Sciences to manufacture ...

Dr Reddy's Laboratories and Hetero, along with other generic drug makers, enter into voluntary licensing agreements with ...

Dr. Reddy’s and Hetero partner with Gilead Sciences to manufacture and distribute Lenacapavir for HIV treatment in LMICs.

Lenacapavir is a US Food and Drug Administration (FDA) approved medication indicated for the treatment of HIV type 1 (HIV-1) ...

Large cap FMCG giant Nestle India Ltd will consider its financial results for July to September 2024 quarter on October 17, ...

Athens hosted the event, which saw students gathered from more than 190 countries around the world. The event aims to inspire ...